CC
CORZW

Covalis Capital’s Core Scientific, Inc. Warrant CORZW Stock Holding History

Covalis Capital’s Portfolio CORZW Stock Details CORZW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-37,498
Closed -$228K – 121
2021
Q3 		$228K Hold
37,498
– – 0.05% 88
2021
Q2 		$189K Buy
+37,498
New +$44.7K 0.06% 98

Other funds holding CORZW

AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $6.36B AUM 28.76% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
ACM
Arosa Capital Management Miami Beach, Florida $561M AUM 283.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Covalis Capital's CORZW Position: Q4 2021 in Review

Covalis Capital sold out of Core Scientific, Inc. Warrant (CORZW) in Q4 2021, closing a stake of 37,498 shares — an estimated $228K sold.

Covalis Capital first reported a position in CORZW in Q2 2021 and held it in 2 quarters. The position peaked at $228K in Q3 2021. 26 funds tracked by Wall St. Rank hold CORZW as of Q4 2021.

  • Covalis Capital reported no remaining Core Scientific, Inc. Warrant position as of Q4 2021 after selling out during the quarter.
  • Covalis Capital sold 37,498 Core Scientific, Inc. Warrant shares in Q4 2021, an estimated $228K.
  • Covalis Capital first reported a position in Core Scientific, Inc. Warrant in Q2 2021 and held it in 2 quarters.
  • Covalis Capital's Core Scientific, Inc. Warrant position peaked at $228K in Q3 2021.
  • 26 funds tracked by Wall St. Rank held Core Scientific, Inc. Warrant as of Q4 2021.

Based on Covalis Capital's 13F filing for Q4 2021, filed 14 Feb 2022.